Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.530
-0.200 (-11.56%)
At close: Apr 28, 2026, 4:00 PM EDT
1.550
+0.020 (1.28%)
After-hours: Apr 28, 2026, 5:16 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $110.62 million as of April 28, 2026. Its market cap has increased by 70.18% in one year.
Market Cap
110.62M
Enterprise Value
68.69M
1-Year Change
70.18%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $110.62M, a decrease of -77.38%. That is a compound annual growth rate of -25.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 125.08M | 42.67% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 134.49M |
| Equillium | 134.36M |
| InflaRx | 130.13M |
| Innate Pharma | 127.25M |
| Aardvark Therapeutics | 121.52M |
| Edesa Biotech | 117.82M |
| Cardiff Oncology | 117.59M |
| Vivani Medical | 115.97M |